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Summary
Antimicrobial resistance of food-related bacterial pathogens is becoming a serious prob-
lem, especially after the emergence of multidrug-resistant strains. To overcome this pro-
blem, new and effective antimicrobials or resistance modulators are highly needed and plant
kingdom represents a valuable source of these compounds. We investigated antimicrobial
and resistance modulatory activity of the phenolic extract, essential oil and post-distilla-
tion extract of Alpinia katsumadai seeds against Campylobacter jejuni and Staphylococcus aure-
us. Among the tested plant formulations, A. katsumadai seed phenolic extract and post-dis-
tillation extract showed moderate antimicrobial activity against C. jejuni, while S. aureus
was more resistant. When evaluating resistance modulatory potential of A. katsumadai phe-
nolic extract, essential oil and post-distillation extract in C. jejuni against ciprofloxacin, ery-
thromycin, triclosan, bile salts and ethidium bromide, plant formulations exhibited modu-
latory activity in combination with all antimicrobials. Modulation of resistance was more
strain- and antimicrobial-specific in S. aureus, but very efficient in the case of reduced resi-
stance to bile salts. Essential oil from A. katsumadai seeds efficiently increased intracellular
ethidium bromide accumulation and was thus confirmed as potential inhibitor of efflux
pumps in C. jejuni and S. aureus.
Key words: antimicrobial activity, antimicrobial resistance, resistance modulation, Alpinia katsu-
madai seed extracts, essential oil, efflux inhibition
Introduction
Despite many recent technological advances in the
food industry, which have contributed to increased safe-
ty in the food supply chain, we are still facing high inci-
dence of foodborne illnesses. Only in 2011, there were
69 553 human cases originating from foodborne zoonotic
outbreaks in the EU (1). Ninety-three of them were fatal.
In the same year, Campylobacter, as the most prevalent
foodborne zoonotic agent, caused 220 209 registered, most-
ly sporadic human illnesses and it is assumed that the real
burden is even much higher (1). Besides emerging and
reemerging food-related zoonotic agents, the non-zoonot-
ic pathogens are also transmitted by foods. Together with
their high incidence and the increasing resistance against
antibiotics and other antimicrobials used in the food chain
(2,3), microbial pathogens compromise food safety, espe-
cially with the emergence of multidrug-resistant strains (4).
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Search for alternative antimicrobials derived from
plants seems to be a viable solution for mitigation of re-
sistance (5). In addition to searching for new antimicro-
bially active plant formulations, the strategies for com-
bating antibiotic resistance are focused also on resistance
modulators. These are not necessarily antimicrobially ac-
tive, but can decrease the resistance of pathogens when
administered together with other antimicrobials. The mi-
crobial sensitization by resistance modulators is mostly
due to efflux inhibition, increased membrane permeabil-
ity, increased porin production or change in porin pro-
file (6).
Plant extracts rich in phenolic compounds (phenolic
extracts), and essential oils have long been shown to
possess antimicrobial activity and were frequently stud-
ied and reviewed (7–10). They are especially interesting
as they are generally recognized as safe and have a po-
tential to be used as preservatives in food products. Alpi-
nia katsumadai Hayata (syn. A. katsumadae Hayata; Zingi-
beraceae) is widely used in traditional Chinese medicine
as an anti-emetic remedy and to increase the appetite,
but also in animal feed, to facilitate rapid growth of do-
mestic animals (11,12). In our study we have focused on
investigating the bioactivity of A. katsumadai extract, es-
sential oil and also waste material that remains after the
essential oil production. Such residual materials are often
disposed of and may present an environmental problem.
Their high phenolic content and the potential to provide
an economically feasible source of natural antioxidants
and antimicrobials is unused (13).
In our study phenolic extract, essential oil and post-
-distillation extract of A. katsumadai seeds were tested
against drug-sensitive and resistant strains of Gram-nega-
tive Campylobacter jejuni and Gram-positive Staphylococ-
cus aureus, and their potential to modulate the resistance
of these pathogens against different antimicrobials was
evaluated. Additionally, intracellular accumulation of ethi-
dium bromide was tested to confirm efflux inhibition
with the plant formulation, which was most efficient in
resistance modulation.
Materials and Methods
Bacterial strains, growth conditions and antibiotic
resistance
All bacterial strains were stored at –80 °C. Campylo-
bacter was grown on Columbia blood agar (Oxoid, Ba-
singstoke, UK) at 42 °C for 24 h under microaerobic con-
ditions. Staphylococcus was grown on Mueller-Hinton agar
(MHA, Oxoid) at 37 °C for 24 h. For the antimicrobial
activity assays, cultures were suspended in Mueller-Hin-
ton broth (MHB, Oxoid) to 105–106 CFU/mL. Antibiotic-
-sensitive and -resistant strains of both species were in-
cluded in testing. Their resistance against five or more
medically important antibiotics was determined by broth
microdilution method (Sensititre® TREK Diagnostic Sys-
tems Inc., Thermo Scientific, Independence, OH, USA)
or CellTiter-Blue® reagent (Promega, Madison, WI, USA)
and automated fluorescence signal detection (14).
Preparation of plant formulations
Alpinia katsumadai seeds were bought from a com-
mercial source (Cat. no. 680381, Plantasia, Oberndorf/
Salzburg, Austria) and extracted with 96 % ethanol for
24 h at room temperature to obtain an extract rich in
phenolic compounds which was dried by gradual pres-
sure decrease at 45 °C using rotavapor. Part of the ex-
tract was suspended in water and hydrodistilled for 2 h
using Clevenger-type apparatus to obtain the essential
oil. The remaining material after hydrodistillation was
freeze-dried and dissolved in ethanol for further testing
as post-distillation extract.
Total phenolic content and DPPH radical-scavenging
assay
The total content of phenolic compounds (TPC) of
tested formulations was determined spectrophotometri-
cally using Folin-Ciocalteu reagent (15). The reaction mix-
ture contained 100 mL of 0.1 % phenolic extract or post-
-distillation extract diluted in methanol, 500 mL of 0.2 M
Folin-Ciocalteu reagent (Fluka Chemicals, AG, Buchs,
Switzerland), and 400 mL of 10 % aqueous Na2CO3 solu-
tion (Lach-Ner, Brno, Czech Republic). The absorbance
was measured spectrophotometrically (Agilent Technol-
ogies, Santa Clara, CA, USA) at 760 nm after a 30-min-
ute incubation in the dark. The results are expressed as
mg of gallic acid equivalents (GAE) per g of tested dried
material.
The radical-scavenging potential of the tested plant
formulations was evaluated using the DPPH assay (16),
with some modifications. Briefly, the samples were dis-
solved in methanol and tested at four concentrations
ranging from 3.75 to 150 mg/mL. The reaction mixtures
contained 50 mL of the sample dilution and 150 mL of 50
mM DPPH dissolved in methanol. Spectrophotometric ab-
sorbance at 535 nm was measured after 30 min, against
methanol as a blank on a Wallac 1420 Victor2 multilabel
counter (PerkinElmer, Waltham, MA, USA). The RSC was
calculated using the following equation:
RSC=[(Ac–As)/Ac]·100 /1/
where As is the absorbance of the sample, and Ac is the
absorbance of the control.
Antimicrobial activity assay
Antimicrobial activity was evaluated using broth mi-
crodilution assay in microtiter plates as previously de-
scribed using CellTiterBlue® kit (Promega) (14). After 24-
-hour incubation under species-specific growth conditions,
viability was measured based on the intensity of the fluo-
rescence signal with a microplate reader (Tecan, Manne-
dorf/Zurich, Switzerland). Minimal inhibitory concentra-
tion (MIC) was determined as the lowest concentration
of the tested antimicrobial at which no fluorescence sig-
nal was detected. Negative control, growth control and
dimethyl sulphoxide (DMSO) control were included and
each assay was repeated in triplicate.
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Resistance modulatory activity assay
The resistance modulatory assay was performed by
the same principle as the antimicrobial activity assay
with the addition of the tested modulators in concentra-
tions of half MIC value into the medium.
Ethidium bromide accumulation assay
Ethidium bromide (EtBr) accumulation assay (17) was
carried out to evaluate the potential efflux inhibitory ac-
tivity of essential oil at 0.5 and 0.25 MICs of essential oil
on C. jejuni NCTC 11168 and S. aureus 5.3. Additionally,
100 mg/mL of verapamil were tested as a positive efflux
inhibitor reference. The overnight cultures were resus-
pended in MHB to achieve A600 nm=0.2 and incubated for
4 h at 37 °C (S. aureus) or 42 °C (C. jejuni). Further on,
the cells were washed and resuspended in phosphate buf-
fered saline (PBS) to achieve A600 nm=0.2. Plant formula-
tions and EtBr at final concentration of 0.5 mg/mL were
added to the culture in black microtitre plates (100 mL
per well). Intracellular EtBr accumulation kinetics was
measured at 500 nm excitation and 608 nm emission wave-
length with a microplate reader (Tecan) for 1 h. Culture
with EtBr, but without inhibitor was used as a baseline
accumulation control and EtBr alone as blank. Three in-
dependent experiments with three replicates were car-
ried out.
Statistical analysis
The results were statistically analyzed using the SPSS®
software, v. 21 (IBM Corp., Armonk, NY, USA). Compar-
isons of the group mean values and the significances of
the differences between the groups were verified by one-
-way ANOVA. Pearson coefficients were calculated for
the correlations between different variables. The results
were considered significant when p£0.05.
Results and Discussion
Phenolic extract, essential oil and the post-distilla-
tion extract of A. katsumadai seeds were tested for their
antimicrobial activity against five C. jejuni and five S. au-
reus isolates. Among each tested bacterial species, antibi-
otic-sensitive and -resistant strains, including multidrug-
-resistant ones, were included (Table 1; 18).
Statistically significant differences between the anti-
microbial activities of different plant formulations were
observed (p<0.0001). According to the average MICs for
Campylobacter (275 mg/mL), A. katsumadai phenolic extract
was the most efficient antimicrobial plant formulation,
followed by A. katsumadai post-distillation extract. Gen-
erally, plant formulations were more effective against C.
jejuni than against S. aureus (Table 1). We could not con-
firm any difference between the antimicrobial activities
of the tested plant formulations against antibiotic-sensi-
tive or resistant strains. They were active also against mul-
tidrug-resistant strains (Table 1).
Besides direct antimicrobial activity, we also tested
and confirmed remarkable resistance modulatory activ-
ity of A. katsumadai extract, essential oil and post-distilla-
tion extract in C. jejuni, as well as in S. aureus (Table 2).
A. katsumadai seed ethanol extract was confirmed for the
first time to modulate antibiotic resistance in Campylo-
bacter in our recent work (12). Here we comparatively
investigated the resistance modulatory potential of addi-
tional A. katsumadai formulations, essential oil and post-
-distillation extract, and the activity of all three formula-
tions in S. aureus, including MRSA strains (Tables 1 and
2). They were tested as modulators in concentrations half
of their MIC on each individual strain of C. jejuni and S.
aureus and in combination with antimicrobials, i.e. two
antibiotics (ciprofloxacin and erythromycin), triclosan, bile
salts and ethidium bromide. The cut-off value of signifi-
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Table 1. Antimicrobial activity of Alpinia katsumadai plant formulations against antibiotic-sensitive and -resistant Campylobacter jejuni
and Staphylococcus aureus strains, including multidrug-resistant ones
MIC/(mg/mL)
C. jejuni
PE PDE EO ERY CIP TET GEN STR CHL
NCTC 11168 250 250 1000 0.25 (S) 0.25 (S) 0.25 (S) 0.25 (S) 2 (S) <2 (S)
ATCC 33560 125 250 1000 1 (S) 0.25 (S) 0.5 (S) 1 (S) 4 (R) 4 (S)
375/06 500 500 2000 128 (R) 32 (R) 0.25 (S) 0.5 (S) <1 (S) <2 (S)
573/03 250 250 4000 1 (S) 32 (R) 2 (S) 0.25 (S) <1 (S) <2 (S)
K49/4 250 1000 2000 0.5 (S) 1 (R) 0.25 (S) 0.25 (S) 2 (S) <2 (S)
S. aureus
PE PDE EO ERY CIP TET GEN PEN MET
5.1 1000 1000 250 0.25 (S) 2 (R) 32 (R) >16 (R) >16 (R)
5.2 1000 1000 2000 >1024 (R) 0.25 (S) <0.5 (S) <0.25 (S) >16 (S)
5.3 1000 1000 4000 0.5 (S) 0.5 (S) <0.5 (S) <0.25 (S) <0.06 (S)
5.5 250 500 2000 0.5 (S) 64 (R) >32 (R) <0.25 (S) 0.008 (R)
5.6 1000 500 4000 0.25 (S) 0.5 (S) 8 (R) <0.25 (S) 0.5 (S)
MIC=minimal inhibitory concentration; PE=A. katsumadai phenolic extract, PDE=A. katsumadai post-distillation extract, EO=A. katsu-
madai essential oil; ERY=erythromycin, CIP=ciprofloxacin, TET=tetracycline, GEN=gentamicin, STR=streptomycin, CHL=chloram-
phenicol, PEN=penicillin, MET=methicillin; R=resistant, S=sensitive. Resistant phenotypes were determined according to EUCAST
breakpoints (18), where these are defined
cant resistance modulation was set at more than twofold
decrease in the MIC of the tested antimicrobial and was
referred to as modulation factor (MF, Table 2). When test-
ing the post-distillation extract and essential oil as mod-
ulators at half of the MIC on C. jejuni, we found that the
mean MF values were 34 and 78, respectively, consider-
ing combinations with all antimicrobials. Testing the phe-
nolic extract, essential oil and post-distillation extract in
S. aureus resulted in mean MFs of 63, 40 and 22, respec-
tively. According to this, the essential oil was the best
modulator in C. jejuni, while in S. aureus the most effec-
tive formulation was the phenolic extract, followed by
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Table 2. Resistance modulatory activity of Alpinia katsumadai plant formulations in Campylobacter jejuni and Staphylococcus aureus
Ciprofloxacin Erythromycin Triclosan Bile salts EtBr
MIC/(mg/mL) MF MIC/(mg/mL) MF MIC/(mg/mL) MF MIC/(mg/mL) MF MIC/(mg/mL) MF
C. jejuni
NCTC 11168 0.25 0.25 32 32 2
+PE* 0.063 4 0.03 8 n.d. n.d. 8 4 0.5 4
+PDE 0.25 1 0.063 4 8 4 0.5 >64 2 2
+EO <0.125 >2 0.004 >64 <0.5 >64 <0.125 >256 <0.078 >256
375/06 32 128 8 >2 1
+PE* 16 2 64 2 n.d. n.d. 4 4 0.25 4
+PDE 16 2 n.d. n.d. 4 2 0.5 >4 0.5 2
+EO <0.5 >64 n.d. n.d. <0.25 >32 <0.016 >128 <0.03 >32
K49/4 1 0.5 32 128 1
+PE* 0.125 8 0.125 4 n.d. n.d. 16 8 0.125 8
+PDE <0.016 >64 <0.125 >4 <0.5 >64 <2 >64 <0.02 >64
+EO <0.016 >64 <0.125 >4 <0.5 >64 <2 >64 <0.02 >64
573/03 32 1 16 8 0.5
+PE* 16 2 0.25 4 n.d. n.d. 4 2 0.125 4
+PDE <2 >16 <0.5 >2 <0.25 >256 <0.25 >32 0.5 1
+EO <2 >16 <0.5 >2 <0.25 >256 <0.25 >32 <0.02 >32
S. aureus
5.1 2 0.25 0.12 4 64
+PE <0.03 >64 <0.03 >8 <0.001 >128 <0.06 >128 16 4
+PDE 2 1 2 1 0.12 1 0. 26 16 32 2
+EO 1 2 1 2 >0.12 <1 1 4 8 8
5.2 0.25 >1024 0.03 >4 8
+PE 0.25 1 >1024 n.d. 0.12 0.25 <0.03 >256 8 1
+PDE 0.06 4 >1024 n.d. <0.001 >32 0.51 >16 4 2
+EO 1 0.25 1024 >1 <0.001 >32 0.26 >32 8 1
5.3 0.5 0.5 0.002 >4 2
+PE 0.25 2 0.06 8 <0.0001 >32 <0.03 >256 <0.03 >64
+PDE 0.25 2 <0.008 >64 0.0001 16 <0.03 >256 <0.03 >64
+EO 0.25 2 0.125 4 0.0001 16 <0.03 >256 <0.03 >64
5.5 64 0.5 0.06 4 4
+PE 32 2 0.25 2 0.06 1 2 2 2 2
+PDE 32 2 1 0.5 >0.06 <1 0.51 8 2 2
+EO 128 0.5 1 0.5 >0.06 <1 1 4 4 1
5.6 0.5 0.25 >1 >8 8
+PE 0.125 4 0.125 2 <0.008 >256 <0.06 >256 2 4
+PDE 0.25 2 0.125 2 >1 n.d. 1 >16 4 2
+EO 0.008 32 <0.004 >128 <0.008 >256 1 >16 <0.06 >128
*The results were previously published with 0.25 MIC of modulators (12). 0.5 MIC=half of minimal inhibitory concentration, 0.25
MIC=quarter of minimal inhibitory concentration; n.d.=not determined; MF=modulation factor; PE=A. katsumadai phenolic extract,
PDE=A. katsumadai post-distillation extract, EO=A. katsumadai essential oil; EtBr=ethidium bromide. Numbers in bold represent si-
gnificant resistance modulatory activity (MF>2)
the essential oil and the post-distillation extract. How-
ever, these differences could not be confirmed as statisti-
cally significant in C. jejuni (p=0.071) nor in S. aureus
(p=0.202). The mean modulation factors of all formula-
tions in combination with individual antimicrobials ranged
from 13 to 93, confirming the high modulation potential
of A. katsumadai seed formulations in C. jejuni. The com-
parative analysis of modulatory activity of A. katsumadai
formulations in C. jejuni confirmed them as equally effi-
cient in combination with different antimicrobials, includ-
ing bile salts (MFmean>55, Table 2). This is important since
the intestinal tract with the presence of bile salts is a nat-
ural environment and reservoir of Campylobacter sp., so
resistance to bile salts is essential for C. jejuni survival
and virulence potential. It was also shown that active
efflux is one of the resistance mechanisms used by C.
jejuni to resist the bactericidal effects of bile salts (19,20).
With this work we confirmed Alpinia formulations to be
very efficient in restoring C. jejuni sensitivity to bile salts
(Table 2) and thus potentially influence its survival and
infection capacity. On the other hand, in S. aureus, there
were significant differences in modulation effects when
formulations were combined with different antimicrobi-
als (p=0.005). The strongest resistance modulation was
achieved in combination with bile salts (MFmean=101),
followed by triclosan (MFmean=57) and ethidium bro-
mide (MFmean=23). The weakest, yet still exceptional in-
crease in sensitivity was obtained when plant formula-
tions were used together with antibiotics, where mean
modulation factor was 18 in the case of erythromycin
and 10 in the case of ciprofloxacin. Phenolic extract and
essential oil were able to restore resistance of S. aureus
5.1 against ciprofloxacin, while all of the tested plant
formulations were able to reverse ciprofloxacin resis-
tance in C. jejuni strain K49/4. Compared to other stud-
ies of resistance modulatory activity of rosemary extract,
vine leaf extract and epigallocatechin gallate in Campy-
lobacter, our plant formulations performed equally good
or better, according to the modulation factors (12,14).
This might also be due to the differences in concentra-
tions of modulators used. In these previous studies the
strain specificity of the resistance modulation had been
observed and this phenomenon was to some degree ob-
served also in our study, especially in S. aureus. Cate-
chins and gallates had previously been investigated as
resistance modulators in methicillin-resistant S. aureus.
Among them, (–)-epicatechin gallates could significantly
decrease the resistance to flucloxacillin, imipenem and
meropenem (21).
There are several possible mechanisms of increasing
susceptibility of bacteria to antibiotics and other antimi-
crobials. The most promising are focusing on increasing
the antibiotic influx by destabilizing lipopolysaccharides
in Gram-negative bacteria and increasing the membrane
permeability, and blocking the efflux using efflux pump
inhibitors (6).
In order to elucidate the mechanism of modulatory
activity of A. katsumadai essential oil in C. jejuni and S.
aureus, we have evaluated its potential to increase the
accumulation of the common efflux pump substrate EtBr,
which is an indicator of the efflux inhibition. The pheno-
lic extract and post-distillation extract were excluded from
the experiments because of the high autofluorescence.
We compared the levels of EtBr accumulation in cultures
treated with half and quarter MIC values of essential oil,
relative to the untreated culture, to evaluate whether it
can potentiate the intracellular EtBr accumulation. The
known efflux pump inhibitor verapamil was included in
the study as a positive reference. The results show sig-
nificant (p<0.0001) increase in the EtBr accumulation in
the presence of A. katsumadai essential oil, compared to
untreated culture of C. jejuni, as well as S. aureus (Figs. 1
and 2). The accumulation of EtBr was 1.7-fold better in
the presence of A. katsumadai essential oil in half of its
MIC than in the presence of positive control, verapamil
(Table 3). The accumulation of EtBr in the presence of
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Fig 1. Ethidium bromide accumulation in Campylobacter jejuni
NCTC 11168 in the presence of Alpinia katsumadai essential oil
and verapamil. RFU=relative fluorescence units; 0.5 MIC=half
of minimal inhibitory concentration, 0.25 MIC=quarter of mini-
mal inhibitory concentration; EtBr=ethidium bromide
Fig. 2. Ethidium bromide accumulation in Staphylococcus aureus
5.3 in the presence of Alpinia katsumadai essential oil and vera-
pamil. RFU=relative fluorescence units; 0.5 MIC=half of mini-
mal inhibitory concentration, 0.25 MIC=quarter of minimal in-
hibitory concentration; EtBr=ethidium bromide
essential oil in half of MIC started to slowly decrease in
C. jejuni after reaching the maximum accumulation after
15 min, whereas the accumulation in the presence of
verapamil increased linearly and did not reach the pla-
teau after 60 min (Fig. 1). Similar mean accumulation of
EtBr in the presence of verapamil was achieved in S.
aureus, but it reached the plateau after 25 min and then
the accumulation started to decrease slowly. The same
trend of EtBr accumulation as in C. jejuni in the presence
of essential oil was observed in S. aureus, but the mean
accumulation in the last 10 min was by 19 % lower than
in C. jejuni. The mean EtBr accumulation values in the
presence of essential oil in quarter of MIC were almost
the same as in the presence of half of MIC (Table 3),
only the time needed to reach the maximum accumula-
tion was different (Figs. 1 and 2). Gradual decrease in
EtBr accumulation after reaching the plateau might be
due to the facilitation of EtBr influx by the essential oil
and insufficient capacity to block the efflux.
Compounds from A. katsumadai had previously been
confirmed to increase the EtBr accumulation in Mycobac-
terium smegmatis (22). Recently, several triterpenoids iso-
lated from Momordica balsamina and coumarins from Me-
sua ferrea exhibited efflux-inhibitory activity in S. aureus
(23,24); however, the activity was not directly compara-
ble, due to the different experiment settings.
Since the phenolic compounds are often identified
as main active biomolecules in plant formulations (25),
we have determined the total phenolic content (TPC) of
the phenolic extract and post-distillation extract (Table 3)
in order to see whether the TPC correlates with their
bioactivity. Essential oil was not expected to be rich in
phenols and therefore it was not tested. The TPC of A.
katsumadai phenolic extract was 24.7 mg/mL, which is
lower than in its post-distillation extract (39.9 mg/mL).
However, the antimicrobial activity of the phenolic ex-
tract was better than of the post-distillation extract in all
bacterial targets (Table 1), which indicates that some valu-
able antimicrobially active compounds have been lost or
deactivated during hydrodistillation. A similar result was
observed in the analysis of resistance modulation. The
phenolic extract had the strongest potential to decrease
the resistance in S. aureus, followed by the essential oil
and the post-distillation extract. In C. jejuni, A. katsuma-
dai essential oil was the best modulator. Post-distillation
extract was compared to the phenolic extract and the es-
sential oil and it was concluded that it is the least effec-
tive modulator, although still showing very good resis-
tance modulation in both, S. aureus as well as in C. jejuni.
This indicates the loss of some bioactive compounds dur-
ing the hydrodistillation of the extract. Since both, phe-
nolic extract and essential oil, had valuable resistance mo-
dulatory activities, it is possible that different compounds,
other than phenolics, are responsible for the activity.
Compared to other plant extracts, also from medici-
nal plants, formulations in our study had comparable or
higher phenolic content (25–27). Plant extracts rich in phe-
nolic compounds often possess good radical scavenging
potential (25); therefore, the DPPH radical scavenging of
the tested plant formulations was determined. As seen
in Table 4, the post-distillation extract, which had a
higher TPC, was also a more effective radical scavenger
(IC50=14.5 mg/mL), compared to the phenolic extract
(IC50=64.7 mg/mL).
All of the tested formulations originate from a plant
that is used traditionally as an anti-emetic remedy, culina-
ry spice and to increase the appetite, as well as in animal
feed to increase growth. They also contain compounds
that are generally recognized as safe or are approved as
food additives by the FDA (8), which is why they have a
good potential to be exploited as natural antimicrobial
and antioxidative preservatives in food products. How-
ever, more research needs to be done to evaluate their
sensorial impacts, activity in the real food model (28),
and to prove that they do not cause any negative side-
-effects, like allergic reactions and irritations (8).
Conclusions
Alpinia katsumadai seed phenolic extract, essential oil
and post-distillation extract showed moderate antimicro-
bial activity against Campylobacter jejuni, while they were
less efficient against Staphylococcus aureus. However, all
tested plant formulations were confirmed as good mod-
ulators of C. jejuni and S. aureus resistance against vari-
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C. jejuni S. aureus
essential oil, 0.5 MIC 5303±39 4300±52
essential oil, 0.25 MIC 5298±31 4211±141
verapamil 3128±41 3045±35
no inhibitor 2335±39 2291±8
EtBr control 832±3 797±2
N=9 N=9
*Ethidium bromide accumulation was calculated from the mea-
surements during the last 10 minutes of each assay. The results
are expressed as mean values±standard deviations. The diffe-
rences between accumulation when essential oil or verapamil
were added are statistically significant (p<0.0001), compared to
the culture without added inhibitor. RFU=relative fluorescence
units; 0.5 MIC=half of minimal inhibitory concentration, 0.25
MIC=quarter of minimal inhibitory concentration; EtBr=ethidi-
um bromide
Table 4. Total phenolic content (TPC) and DPPH radical scaven-




per g of d.m.
IC50/(mg/mL)
phenolic extract 24.7±0.2 64.7±6.5




GAE=gallic acid equivalents; d.m.=dried material; n.d.=not de-
termined
ous antimicrobials, including antibiotics and bile salts.
Modulatory activity of A. katsumadai essential oil was
confirmed to be at least partly due to the efflux pump
inhibition, when tested with ethidium bromide accumu-
lation assay. All tested plant formulations have a poten-
tial to be used as natural preservatives and functional
additives in food products.
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